
Product Insights
Efferalgan is a 1000 mg paracetamol tablet marketed by UPSA for the rapid relief of pain and fever. While the active ingredient provides reliable analgesic and antipyretic effects, the tablet is classified as ultra-processed (NOVA 4) and contains several additives such as aspartame, sodium benzoate, multiple sugars and lactose, which may be problematic for people with diabetes, lactose intolerance, or phenylketonuria. Consumers should follow dosing instructions carefully and be aware of the potential for allergic reactions and contraindications, especially in individuals with liver disease or hypersensitivity to any of the listed excipients.
Comparative Analysis
Positioned as a fast-acting, sweetened paracetamol tablet, Efferalgan differentiates itself in the over-the-counter analgesic market by combining a high 1000 mg dose with a palatable formulation that uses artificial sweeteners and preservatives to improve taste and shelf-life.
Ingredients
aspartame(E951), benzoate de sodium (E211),fructose,glucose,lactose, saccharose, sodium, sorbitol (E420)traces éthanol
Unlock Full Product Insights
Scan this and millions of other daily products to reveal hidden ingredients, safety alerts, and comprehensive analysis with the free NutrScan app.
Frequently Asked Questions
Everything you need to know about Efferalgan.







